Impact of Daily Oral Cannabis Doses in Patients With Cancer (NCT06601218)
A Phase I Study of the Effects of Cannabis on Cancer Burden: Placebo-Controlled, Double-Blind, Randomized Trial
🩺 Plain-English Summary (8th-Grade Level)
This study will enroll patients with cancer and participants will be randomized to receive one dose of cannabis for approximately 4 months. There is a 3/4 (or 75%) chance that a participant will receive an active cannabis dose in the study. There is a 1/4 (or 25% chance) that a participant will receive a placebo dose (meaning a blank dose/no cannabis/no active drug). The goals of this study are to determine 1) the safety and tolerability of cannabis in individuals with cancer and 2) if cannabis can help with the side effects of cancer and cancer treatment - including nausea and vomiting, appetite, pain, sleep, and quality of life.
Who can join: Review the eligibility criteria below.
Location: University of Kentucky — Lexington, Kentucky
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- University of Kentucky — Lexington, Kentucky
📞 Contact the Study Coordinator
Phone: (859) 257-4581
Email: grayson.fuller@uky.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
- 💵 Compensation indicated: There is a 3/4 (or 75%) chance that a participant will receive an active cannabis dose in the study.
More studies in Cancer
- Intra- and Inter-fraction Changes in Radiation Therapy — Milwaukee, Wisconsin
- TREC@TAMU Cancer Prevention Registry and Repository — Bryan, Texas
- The Florida ASCENT Study — Gainesville, Florida
- Ovarian Tissue Cryopreservation in Children — Rochester, Minnesota
- Revealing Information Genuinely & Honestly Across Time - Communication Preferences Visit — Memphis, Tennessee
- Investigating Real-Time Immunotherapy Symptoms Study — Pittsburgh, Pennsylvania
Explore by condition: All Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.